Consumer Discretionary • Specialty Chemicals
$74.38 ▲ +1.71
(+2.35%)
MKT CAP: $3.41B • VOL: 545.5K
52W L $47 52W H $78
CONSENSUS RATING DISTRIBUTION (40 DESKS)
BUY: 30 HOLD: 8
SELL: 2
12M STREET TARGET RANGE
IMPLIED: +14.0%
LOW
$62
MEDIAN
$83
MEAN
$85
HIGH
$101
STREET BS CREDIBILITY SCORE 1Y BACKTESTED
68/100
EMPIRICAL HIT RATE VS SPOT
GRADES WHETHER SELL-SIDE TARGET REVISIONS LEAD OR CHASE ASH TAPE
ASH // FIRM-BY-FIRM ANALYST BACKTEST & BS DETECTOR (ANR <GO>)
CURRENT 90D STREET CONSENSUS
| INSTITUTION / ANALYST | ACTION | RATING | TARGET | PRIOR PT | CALL DATE | PX AT CALL | RET SINCE CALL | 1Y ACCURACY | BS GRADE |
|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley Institutional Equity Desk | REITERATE | OUTPERFORM | $90.00 | $85.54 | 2025-02-14 | $67.69 | +9.9% | 78% | A |
| Goldman Sachs Global Research Sector Coverage | TARGET REV | STRONG BUY | $93.72 | $87.77 | 2025-02-06 | $69.92 | +6.4% | 74% | A |
| J.P. Morgan Securities US Large Cap | REITERATE | BUY | $84.79 | $81.82 | 2025-01-29 | $71.40 | +4.2% | 67% | B |
| Bernstein Autonomous Forensic Coverage | INITIATE | HOLD | $75.87 | — | 2025-01-17 | $72.89 | +2.0% | 61% | B |
| Barclays Capital Americas Research | DOWNGRADE | UNDERPERFORM | $65.45 | $70.66 | 2025-01-09 | $66.20 | -11.2% | 42% | D |
| UBS Investment Bank Institutional Desk | UPGRADE | BUY | $88.51 | $77.36 | 2024-12-18 | $64.71 | +14.9% | 72% | A |
| Citigroup Global Markets Sector Lead | TARGET REV | HOLD | $72.15 | $75.12 | 2024-12-04 | $69.17 | -4.3% | 48% | C |